Bi, Jingtao <br/><br/>
Txr1: an important factor in oxaliplatin resistance in gastric cancer.  [electronic resource] 

 -  Medical oncology (Northwood, London, England)  Feb 2014 
 - 807 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1559-131X 
<br/><br/><label>Standard No.: </label>10.1007/s12032-013-0807-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--therapeutic use<br/>Basic Helix-Loop-Helix Leucine Zipper Transcription Factors--genetics<br/>Blotting, Western<br/>Cell Cycle--drug effects<br/>Cell Proliferation--drug effects<br/>Drug Resistance, Neoplasm<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Immunoenzyme Techniques<br/>Inhibitor of Apoptosis Proteins--genetics<br/>Lymphatic Metastasis<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Organoplatinum Compounds--therapeutic use<br/>Oxaliplatin<br/>Prognosis<br/>RNA, Messenger--genetics<br/>RNA, Small Interfering--genetics<br/>Real-Time Polymerase Chain Reaction<br/>Repressor Proteins--antagonists & inhibitors<br/>Retrospective Studies<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Stomach Neoplasms--drug therapy<br/>Survival Rate<br/>Survivin<br/>Tumor Cells, Cultured